Reuters logo
BRIEF-Vaccinex announces clinical collaboration with Merck Kgaa
October 6, 2016 / 1:52 PM / a year ago

BRIEF-Vaccinex announces clinical collaboration with Merck Kgaa

Oct 6 (Reuters) - Vaccinex Inc:

* Vaccinex announces clinical collaboration with Merck Kgaa, Darmstadt, Germany, to evaluate the combination of VX15/2503, and avelumab in non-small cell lung cancer

* Vaccinex will be responsible for conducting planned phase IB/II clinical trial

* Further details of collaboration were not disclosed Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below